Explore News
-
Cancer Treatment Breaks Ground with Doubling Survival Rate
A daily pill brings new hope to patients with the deadliest cancer
-
How Scientists Cracked the Code on “Undruggable” Cancer
A new drug targets the KRAS mutation, offering hope for patients
-
Why daily pill is a breakthrough for pancreatic cancer
Breakthrough drug daraxonrasib hailed as a game-changer
-
Why a new pill is a gamechanger for pancreatic cancer patients
New treatment brings hope to patients with advanced pancreatic cancer
-
Experimental Pill Increases Survival Rate by 90%
New hope for patients with advanced pancreatic cancer as experimental pill shows promising results
-
FDA Opens Early Access to Daraxonrasib for 8,000 PDAC Patients
The FDA’s move to expand access to daraxonrasib offers new hope for patients with metastatic…
